Exponent (EXPO) closed at $80.26 on October 30, 2026, up 2.5% from the previous close, on volume of 736,528 shares (30-day average 598,708).
Data as of October 30, 2026.
30-Oct-2026
Exponent declares $0.31 dividend
Seeking Alpha News (Thu, 29-Oct 5:22 PM ET)
Exponent GAAP EPS of $0.64 beats by $0.04, revenue of $173.7M beats by $20.27M
Seeking Alpha News (Thu, 29-Oct 5:00 PM ET)
Exponent Posts Strong Q3 Results, Raises 2026 Outlook
TipRanks (Thu, 29-Oct 4:48 PM ET)
Exponent Reports Third Quarter 2026 Financial Results
Globe Newswire (Thu, 29-Oct 4:05 PM ET)
Exponent Declares Regular Quarterly Dividend for Q4 2026
Globe Newswire (Thu, 29-Oct 4:05 PM ET)
Exponent Q3 2026 Earnings Preview
Seeking Alpha News (Wed, 28-Oct 5:35 PM ET)
Globe Newswire (Thu, 8-Oct 4:05 PM ET)
Globe Newswire (Tue, 29-Sep 10:00 PM ET)
Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.
Exponent trades on the NASDAQ stock market under the symbol EXPO.
As of October 30, 2026, EXPO stock price climbed to $80.26 with 736,528 million shares trading.
EXPO has a beta of 0.30, meaning it tends to be less sensitive to market movements. EXPO has a correlation of 0.01 to the broad based SPY ETF.
EXPO has a market cap of $3.82 billion. This is considered a Mid Cap stock.
Last quarter Exponent reported $174 million in Revenue and $.64 earnings per share. This beat revenue expectation by $21 million and exceeded earnings estimates by $.02.
In the last 3 years, EXPO traded as high as $115.75 and as low as $51.91.
The top ETF exchange traded funds that EXPO belongs to (by Net Assets): IJH, IWM, VTI, SDVY, VB.
EXPO has outperformed the market in the last year with a price return of +22.0% while the SPY ETF gained +12.3%. EXPO has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +24.8% and +11.7%, respectively, while the SPY returned +2.1% and -1.0%, respectively.
EXPO support price is $76.79 and resistance is $79.83 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EXPO shares will trade within this expected range on the day.